In 2002, GlaxoSmithKline was faced with the threat of losing almost $5 million dollars in sales when they had to discontinue Becotide/Becloforte, due to an international agreement to phase out CFC containing products.
Upgrade Campaign
Agency: Insight
Consultants
Advertiser: GlaxoSmithKline
Awards: Consumer Durables (Gold)
Marketing Challenge
Over the last 10 years GlaxoSmithKline has grown to
becomeNew Zealand's largest supplier of asthma medicines. Early in 2002...